USAR's 13% Rebound Is an Oversold Bounce Straight Into Insider Selling

The Bounce Has No Headline

USAR is up 13% over the last day to $22.75, and there is no company-specific news to point at. The last hard catalyst already happened: on June 3 the company finalized definitive agreements with the Commerce Department for access to up to $1.6 billion in CHIPS Act capital, and the stock sold the news — fading about 11% on June 5 from a $27.10 close and bleeding into the low $20s. This week's move is the other side of that trade: an oversold rebound. The bounce was already building before today; the Motley Fool had USAR trading at $22.64 on June 8. Treat it as price action recovering from a too-fast selloff, not a reaction to anything new out of the company.

The Rebound Runs Into a Director Selling

The most specific thing about this bounce is where it is stalling. On June 8, USA Rare Earth director Carolyn Trabuco sold 13,000 shares for roughly $295,984, at prices between $22.760 and $22.785. USAR is changing hands at $22.75 right now — essentially the exact level an insider was distributing into three days ago. That is not a conspiracy, it is supply. When a stock claws back to the price where insiders were comfortable selling, the overhead gets heavier, and a 13% snap-back into that zone is exactly where you would expect the easy part of the move to end.

The Sector Bid Is Real, the Fundamentals Aren't There Yet

What is actually underwriting rare earth names is China. Beijing's Announcement No. 61 tightened rare earth and magnet export controls to the strictest on record, with military-affiliated buyers largely cut off — though China has since paused several of those controls, so the squeeze narrative is currently louder than the reality on the ground. Peers are riding the theme regardless: MP Materials is up over 30% on the month near $57 with real NdPr production and Apple and GM offtake. USAR is the high-beta version of the same trade and far less proven — effectively pre-revenue at scale, with Q1 revenue of $5.7 million against a $66.9 million net loss and a 52-week range of $9.32 to $43.98 that shows how violently it reprices in both directions. The $1.6B headline that anchors the bull case is mostly a milestone-gated loan facility plus about $277 million in grants, not cash in hand. The sector tailwind is genuine; this particular leg up is mostly mean reversion.